Amgen Inc. 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-05 4:35 pm Sale |
2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
AMGEN INC AMGN |
1,508,375 4.344% |
-397,323 (-20.85%) |
Filing |